This feasibility trial is enrolling 16 participants with chronic traumatic spinal cord injury to test the safety of an experimental drug (EG110A) designed to help manage urinary incontinence. If included, participants will receive a single course of multiple injections of EG110A directly into the bladder muscle at either a high, medium, or low dose. Final testing of safety and tolerability will be performed after 1 year.
Traumatic
Type
Details
- Participants will receive a single course of multiple injections of EG110A directly into the bladder muscle at either a high, medium, or low dose. - EG110A is an experimental drug designed to help manage urinary incontinence. - Final testing of safety and tolerability will be performed after the intervention.
Main benefits
Bladder health/function
Additional benefits
General health
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more